Suppression of deferoxamine mesylate treatment-induced side effects by coadministration of isoniazid in a patient with Alzheimer's disease subject to aluminum removal by ionspecific chelation.

Source:http://linkedlifedata.com/resource/pubmed/id/2225704

Download in:

View as

General Info

PMID
2225704